NC
MDXG icon

NovaPoint Capital’s MiMedx Group MDXG Stock Holding History

NovaPoint Capital’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-57,964
Closed -$508K – 140
2023
Q4 		$508K Sell
57,964
-50,191
-46% -$368K 0.19% 87
2023
Q3 		$788K Sell
108,155
-52,894
-33% -$394K 0.31% 76
2023
Q2 		$1.06M Sell
161,049
-3,556
-2% -$18.1K 0.4% 62
2023
Q1 		$561K Sell
164,605
-17,528
-10% -$67.9K 0.23% 78
2022
Q4 		$506K Sell
182,133
-118,866
-39% -$355K 0.22% 82
2022
Q3 		$864K Sell
300,999
-50,138
-14% -$178K 0.39% 64
2022
Q2 		$1.22M Sell
351,137
-33,395
-9% -$131K 0.53% 61
2022
Q1 		$1.81M Sell
384,532
-9,503
-2% -$46.5K 0.66% 59
2021
Q4 		$2.38M Hold
394,035
– – 0.85% 47
2021
Q3 		$2.39M Sell
394,035
-186,695
-32% -$2.1M 0.96% 44
2021
Q2 		$7.26M Buy
580,730
+3,568
+0.6% +$38.6K 3.01% 3
2021
Q1 		$5.95M Sell
577,162
-21,956
-4% -$212K 2.78% 7
2020
Q4 		$5.44M Buy
+599,118
New +$4.31M 2.84% 7

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NovaPoint Capital's MDXG Position: Q1 2024 in Review

NovaPoint Capital sold out of MiMedx Group (MDXG) in Q1 2024, closing a stake of 57,964 shares — an estimated $508K sold.

NovaPoint Capital first reported a position in MDXG in Q4 2020 and held it in 13 quarters. The position peaked at $7.26M in Q2 2021. 202 funds tracked by Wall St. Rank hold MDXG as of Q1 2024.

  • NovaPoint Capital reported no remaining MiMedx Group position as of Q1 2024 after selling out during the quarter.
  • NovaPoint Capital sold 57,964 MiMedx Group shares in Q1 2024, an estimated $508K.
  • NovaPoint Capital first reported a position in MiMedx Group in Q4 2020 and held it in 13 quarters.
  • NovaPoint Capital's MiMedx Group position peaked at $7.26M in Q2 2021.
  • 202 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2024.

Based on NovaPoint Capital's 13F filing for Q1 2024, filed 16 Apr 2024.